Malin S Nilsson

7PUBLICATIONS
23CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2025
Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.

Malin S Nilsson, Anna Martner, Lovisa Wennström

|Mar 07, 2025
Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Hana Komic, Tessa Schmachtel, Catia Simoes

|Jun 27, 2019
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.

Malin S Nilsson, Alexander Hallner, Mats Brune

|Oct 14, 2018
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.

Hanna Grauers Wiktorin, Malin S Nilsson, Roberta Kiffin

Pageof 2